Cargando…
Fidelity, tolerability and safety of acute high-intensity interval training after hospitalisation for COVID-19: a randomised cross-over trial
Objectives. Many patients with COVID-19 suffer from persistent symptoms, many of which may potentially be reversed by high-intensity interval training (HIIT). Yet, the safety and tolerability of HIIT after COVID-19 is controversial. This study aimed to investigate the fidelity, tolerability and safe...
Autores principales: | Foged, Frederik, Rasmussen, Iben Elmerdahl, Bjørn Budde, Josephine, Rasmussen, Rasmus Syberg, Rasmussen, Villads, Lyngbæk, Mark, Jønck, Simon, Krogh-Madsen, Rikke, Lindegaard, Birgitte, Ried-Larsen, Mathias, Berg, Ronan Martin Griffin, Christensen, Regitse Højgaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413475/ https://www.ncbi.nlm.nih.gov/pubmed/34493958 http://dx.doi.org/10.1136/bmjsem-2021-001156 |
Ejemplares similares
-
Protective potential of high-intensity interval training on cardiac structure and function after COVID-19: protocol and statistical analysis plan for an investigator-blinded randomised controlled trial
por: Rasmussen, Iben Elmerdahl, et al.
Publicado: (2021) -
Fidelity and tolerability of two high-intensity interval training protocols in patients with COPD: a randomised cross-over pilot study
por: Nymand, Stine Buus, et al.
Publicado: (2023) -
Effect of a 12-week high-intensity exercise intervention: a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis – study protocol for a randomised controlled trial
por: Jønck, Simon, et al.
Publicado: (2023) -
Interleukin-6 May Not Affect Bone Resorption Marker CTX or Bone Formation Marker P1NP in Humans
por: Lehrskov, Louise L, et al.
Publicado: (2020) -
Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes—A Systematic Review
por: Viggers, Rikke, et al.
Publicado: (2023)